Postpartum thyroiditis differential diagnosis: Difference between revisions
Sunny Kumar (talk | contribs) |
Ahmed Younes (talk | contribs) No edit summary |
||
(11 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | [[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Postpartum_thyroiditis]] | ||
{{ | {{CMG}} {{AE}} {{MMF}}{{SKA}} | ||
==Overview== | ==Overview== | ||
[[Postpartum thyroiditis]] must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Hashimoto | [[Postpartum thyroiditis]] must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Hashimoto's thyroiditis]], [[Riedel's thyroiditis]], and suppurative thyroiditis. Postpartum thyroiditis must also be differentiated from other diseases which cause [[hypothyroidism]]. As postpartum thyroiditis may cause transient thyrotoxic symptoms, the diseases causing [[thyrotoxicosis]] must also be considered in the differential diagnosis. | ||
==Differentiating Postpartum Thyroiditis from other Diseases== | ==Differentiating Postpartum Thyroiditis from other Diseases== | ||
Line 15: | Line 15: | ||
! style="background:#4479BA; color: #FFFFFF;" | Conditions | ! style="background:#4479BA; color: #FFFFFF;" | Conditions | ||
! style="background:#4479BA; color: #FFFFFF;" |Causes | ! style="background:#4479BA; color: #FFFFFF;" |Causes | ||
! style="background:#4479BA; color: #FFFFFF;" |Age | ! style="background:#4479BA; color: #FFFFFF;" |Age of onset (years) | ||
! style="background:#4479BA; color: #FFFFFF;" |Pathological findings | ! style="background:#4479BA; color: #FFFFFF;" |Pathological findings | ||
! style="background:#4479BA; color: #FFFFFF;" |Diagnostic approach | ! style="background:#4479BA; color: #FFFFFF;" |Diagnostic approach | ||
Line 22: | Line 22: | ||
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis]] | | align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Autoimmune | *[[Autoimmune]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*All ages, peak at 30-50 | *All ages, peak at 30-50 | ||
Line 28: | Line 28: | ||
*Lymphocytic infiltration | *Lymphocytic infiltration | ||
*Germinal centers | *Germinal centers | ||
*Fibrosis (in some variants) | *[[Fibrosis]] (in some variants) | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) | *[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) | ||
*[[Thyroid peroxidase|TPO antibodies]] present in high titer | *[[Thyroid peroxidase|TPO antibodies]] present in high titer | ||
*[[I-123 thyroid imaging|I-123]] uptake usually decreased | *[[I-123 thyroid imaging|I-123]] uptake usually decreased | ||
Line 41: | Line 41: | ||
*20-60 | *20-60 | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Giant cells | *[[Giant cells]] | ||
*Granulomas | *[[Granulomas]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) and/or | *[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) and/or | ||
* [[Thyroid function tests|Decreased TSH]] ( | * [[Thyroid function tests|Decreased TSH]] ([[thyrotoxicosis]]) | ||
*[[Thyroid peroxidase|TPO antibodies]] absent or very low titer | *[[Thyroid peroxidase|TPO antibodies]] absent or very low titer | ||
*[[I-123 thyroid imaging|I-123]] uptake decreased | *[[I-123 thyroid imaging|I-123]] uptake decreased | ||
Line 51: | Line 51: | ||
| align="center" style="background:#DCDCDC;" |[[Silent thyroiditis]] | | align="center" style="background:#DCDCDC;" |[[Silent thyroiditis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Autoimmune | *[[Autoimmune]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*All ages, peak at 30-40 | *All ages, peak at 30-40 | ||
Line 58: | Line 58: | ||
*Lymphoid follicles | *Lymphoid follicles | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) and/or | *[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) and/or | ||
* [[Thyroid function tests|Decreased TSH]] (transient hypothyroidism) | * [[Thyroid function tests|Decreased TSH]] (transient [[hypothyroidism]]) | ||
*[[Thyroid peroxidase|TPO antibodies]] present in high titer | *[[Thyroid peroxidase|TPO antibodies]] present in high titer | ||
*[[I-123 thyroid imaging|I-123]] uptake usually decreased | *[[I-123 thyroid imaging|I-123]] uptake usually decreased | ||
Line 65: | Line 65: | ||
| align="center" style="background:#DCDCDC;" |[[Postpartum thyroiditis]] | | align="center" style="background:#DCDCDC;" |[[Postpartum thyroiditis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Autoimmune | *[[Autoimmune]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Childbearing age | *Childbearing age | ||
Line 71: | Line 71: | ||
*Lymphocytic infiltration | *Lymphocytic infiltration | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) and/or | *[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) and/or | ||
* [[Thyroid function tests|Decreased TSH]] (transient hypothyroidism) | * [[Thyroid function tests|Decreased TSH]] (transient [[hypothyroidism]]) | ||
*[[Thyroid peroxidase|TPO antibodies]] present in high titer | *[[Thyroid peroxidase|TPO antibodies]] present in high titer | ||
*[[I-123 thyroid imaging|I-123]] uptake usually decreased | *[[I-123 thyroid imaging|I-123]] uptake usually decreased | ||
Line 82: | Line 82: | ||
*30-60 | *30-60 | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Dense fibrosis | *Dense [[fibrosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*[[Thyroid function tests|Normal TSH]] (euthyroidism) | *[[Thyroid function tests|Normal TSH]] (euthyroidism) | ||
Line 90: | Line 90: | ||
| align="center" style="background:#DCDCDC;" |[[Suppurative thyroiditis]] | | align="center" style="background:#DCDCDC;" |[[Suppurative thyroiditis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Infection | *[[Infection]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Children, 20-40 | *Children, 20-40 | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Abscess formation | *[[Abscess]] formation | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*[[Thyroid function tests|Normal TSH]] (euthyroidism) | *[[Thyroid function tests|Normal TSH]] (euthyroidism) | ||
Line 120: | Line 120: | ||
|- | |- | ||
| rowspan="3" style="background:#DCDCDC;" |[[Primary hypothyroidism]] | | rowspan="3" style="background:#DCDCDC;" |[[Primary hypothyroidism]] | ||
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis|Autoimmune]] ([[Hashimoto's thyroiditis]]) | | align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis|Autoimmune]] | ||
([[Hashimoto's thyroiditis]]) | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
Line 146: | Line 147: | ||
*[[Riedel's thyroiditis]] usually presents with hard and fixed thyroid mass. | *[[Riedel's thyroiditis]] usually presents with hard and fixed thyroid mass. | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" | | | align="center" style="background:#DCDCDC;" |Infectious thyroiditis | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | ||
Line 219: | Line 220: | ||
| align="center" style="background:#DCDCDC;" |Trauma induced | | align="center" style="background:#DCDCDC;" |Trauma induced | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |Radioiodine induced | | align="center" style="background:#DCDCDC;" |[[Radioiodine]] induced | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |Thyroidectomy | | align="center" style="background:#DCDCDC;" |[[Thyroidectomy]] | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |Subclinical hypothyroidism | | align="center" style="background:#DCDCDC;" |Subclinical hypothyroidism | ||
Line 237: | Line 238: | ||
|- | |- | ||
|} | |} | ||
<br style="clear:left" />''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies. (*)[[TSH]] may be decreased transiently in the [[thyrotoxicosis]]. (**)TPOAb may be present in drug-induced [[Hypothyroidism| | <br style="clear:left" />''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies. (*)[[TSH]] may be decreased transiently in the [[thyrotoxicosis]]. (**)TPOAb may be present in drug-induced [[Hypothyroidism|hypothyroidism]] or [[hyperthyroidism]] such as [[Interferon-alpha]], [[Interleukin 2|interleukin-2]], and [[lithium]].'' | ||
===Differentiating postpartum thyroiditis from other causes of thyrotoxicosis=== | ===Differentiating postpartum thyroiditis from other causes of thyrotoxicosis=== | ||
*Postpartum thyroiditis can initially present with thyrotoxicosis which must be differentiated from other causes of thyrotoxicosis.<ref name="pmid16734054">{{cite journal |vauthors=Bindra A, Braunstein GD |title=Thyroiditis |journal=Am Fam Physician |volume=73 |issue=10 |pages=1769–76 |year=2006 |pmid=16734054 |doi= |url=}}</ref><ref name="pmid19949140">{{cite journal |vauthors=McDermott MT |title=In the clinic. Hypothyroidism |journal=Ann. Intern. Med. |volume=151 |issue=11 |pages=ITC61 |year=2009 |pmid=19949140 |doi=10.7326/0003-4819-151-11-200912010-01006 |url=}}</ref><ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref><ref name="pmid18177256">{{cite journal |vauthors=Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR |title=Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002) |journal=Thyroid |volume=17 |issue=12 |pages=1211–23 |year=2007 |pmid=18177256 |doi=10.1089/thy.2006.0235 |url=}}</ref><ref name="pmid18415684">{{cite journal |vauthors=Lania A, Persani L, Beck-Peccoz P |title=Central hypothyroidism |journal=Pituitary |volume=11 |issue=2 |pages=181–6 |year=2008 |pmid=18415684 |doi=10.1007/s11102-008-0122-6 |url=}}</ref><ref name="pmid25905413">{{cite journal |vauthors=De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J |title=Clinical Strategies in the Testing of Thyroid Function |journal= |volume= |issue= |pages= |year= |pmid=25905413 |doi= |url=}}</ref><ref name="urlClinical Finding and Thyroid Function in Women with Struma Ovarii">{{cite web |url=https://www.hindawi.com/archive/2013/717584/ |title=Clinical Finding and Thyroid Function in Women with Struma Ovarii |format= |work= |accessdate=}}</ref><ref name="pmid25146390">{{cite journal |vauthors=Vaidya B, Pearce SH |title=Diagnosis and management of thyrotoxicosis |journal=BMJ |volume=349 |issue= |pages=g5128 |year=2014 |pmid=25146390 |doi= |url=}}</ref><ref name="urlThink thyrotoxicosis factitia - measure thyroglobulin | The BMJ">{{cite web |url=http://www.bmj.com/content/349/bmj.g5128/rr/763450 |title=Think thyrotoxicosis factitia - measure thyroglobulin | The BMJ |format= |work= |accessdate=}}</ref> | *Postpartum thyroiditis can initially present with [[thyrotoxicosis]] which must be differentiated from other causes of [[thyrotoxicosis]].<ref name="pmid16734054">{{cite journal |vauthors=Bindra A, Braunstein GD |title=Thyroiditis |journal=Am Fam Physician |volume=73 |issue=10 |pages=1769–76 |year=2006 |pmid=16734054 |doi= |url=}}</ref><ref name="pmid19949140">{{cite journal |vauthors=McDermott MT |title=In the clinic. Hypothyroidism |journal=Ann. Intern. Med. |volume=151 |issue=11 |pages=ITC61 |year=2009 |pmid=19949140 |doi=10.7326/0003-4819-151-11-200912010-01006 |url=}}</ref><ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref><ref name="pmid18177256">{{cite journal |vauthors=Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR |title=Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002) |journal=Thyroid |volume=17 |issue=12 |pages=1211–23 |year=2007 |pmid=18177256 |doi=10.1089/thy.2006.0235 |url=}}</ref><ref name="pmid18415684">{{cite journal |vauthors=Lania A, Persani L, Beck-Peccoz P |title=Central hypothyroidism |journal=Pituitary |volume=11 |issue=2 |pages=181–6 |year=2008 |pmid=18415684 |doi=10.1007/s11102-008-0122-6 |url=}}</ref><ref name="pmid25905413">{{cite journal |vauthors=De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J |title=Clinical Strategies in the Testing of Thyroid Function |journal= |volume= |issue= |pages= |year= |pmid=25905413 |doi= |url=}}</ref><ref name="urlClinical Finding and Thyroid Function in Women with Struma Ovarii">{{cite web |url=https://www.hindawi.com/archive/2013/717584/ |title=Clinical Finding and Thyroid Function in Women with Struma Ovarii |format= |work= |accessdate=}}</ref><ref name="pmid25146390">{{cite journal |vauthors=Vaidya B, Pearce SH |title=Diagnosis and management of thyrotoxicosis |journal=BMJ |volume=349 |issue= |pages=g5128 |year=2014 |pmid=25146390 |doi= |url=}}</ref><ref name="urlThink thyrotoxicosis factitia - measure thyroglobulin | The BMJ">{{cite web |url=http://www.bmj.com/content/349/bmj.g5128/rr/763450 |title=Think thyrotoxicosis factitia - measure thyroglobulin | The BMJ |format= |work= |accessdate=}}</ref> | ||
{| class="wikitable" align="center" style="border: 0px; margin: 3px;" | {| class="wikitable" align="center" style="border: 0px; margin: 3px;" | ||
! colspan="2" rowspan="2" align="center" style="background: #4479BA; color: #FFFFFF; " |Disease | ! colspan="2" rowspan="2" align="center" style="background: #4479BA; color: #FFFFFF; " |Disease | ||
Line 250: | Line 251: | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Pain | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Pain | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Free T4 | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small>Free T4 | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3 | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3 | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3RU<small>† | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3RU<small>† | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Thyroglobin | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small>Thyroglobin | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TRH | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TRH | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH Receptor Antibody | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH Receptor Antibody | ||
Line 328: | Line 329: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * Opthalmopathy and [[dermopathy]] may be present | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |[[Toxic thyroid nodule]] | | align="center" style="background:#DCDCDC;" |[[Toxic thyroid nodule]] | ||
Line 357: | Line 358: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Inappropriately normal or increased TSH | *Inappropriately normal or increased [[TSH]] | ||
|- | |- | ||
| rowspan="1" style="background:#DCDCDC;" |[[Tertiary hyperthyroidism]] | | rowspan="1" style="background:#DCDCDC;" |[[Tertiary hyperthyroidism]] | ||
Line 372: | Line 373: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Inappropriately normal or increased TSH | *Inappropriately normal or increased [[TSH]] | ||
|- | |- | ||
| rowspan="2" style="background:#DCDCDC;" |Drug induced | | rowspan="2" style="background:#DCDCDC;" |Drug induced | ||
Line 387: | Line 388: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
*High urinary iodine | *High urinary [[iodine]] | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |[[Amiodarone|Amiodarone type 2]] | | align="center" style="background:#DCDCDC;" |[[Amiodarone|Amiodarone type 2]] | ||
Line 401: | Line 402: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
*High urinary iodine | *High urinary [[iodine]] | ||
|- | |- | ||
| rowspan="3" style="background:#DCDCDC;" |Others | | rowspan="3" style="background:#DCDCDC;" |Others | ||
Line 416: | Line 417: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Decreased thyroglobulin | *Decreased [[thyroglobulin]] | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |[[Trophoblastic disease]] | | align="center" style="background:#DCDCDC;" |[[Trophoblastic disease]] | ||
Line 449: | Line 450: | ||
<small>''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies.''</small> | <small>''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies.''</small> | ||
===Differentiating various diseases on the basis of type of thyroid dysfunction=== | |||
{| class="wikitable" | {| class="wikitable" | ||
! rowspan="2" |Stages | ! rowspan="2" |Stages | ||
! rowspan="2" |Peek | ! rowspan="2" |Peek | ||
presenting purpural | presenting | ||
purpural | |||
month | month | ||
! rowspan="2" |Disease | ! rowspan="2" |Disease | ||
Line 480: | Line 482: | ||
!Persistent | !Persistent | ||
hyperthyroidism | hyperthyroidism | ||
|4-6 | |||
|[[Grave's disease]] | |||
| + | |||
|Small | |||
painful | painful | ||
mass | mass | ||
| + | |||
| + | |||
Early | |||
|↓ | |||
|↑↑ | |||
|Neg | |||
|↑ | |||
|↑ | |||
|Diffusely | |||
enlarged | enlarged | ||
Line 504: | Line 506: | ||
echotexture | echotexture | ||
|hyperplastic | |||
hyperplastic | |||
follicles due to | follicles due to | ||
Line 514: | Line 515: | ||
scalloping | scalloping | ||
|TSHR | |||
activating | activating | ||
Line 522: | Line 523: | ||
! rowspan="5" |Transient | ! rowspan="5" |Transient | ||
hyperthyroidism | hyperthyroidism | ||
| rowspan="5" |2-4 | |||
|[[Silent thyroiditis]] | |||
| + | |||
|Small | |||
painless | painless | ||
goiter | goiter | ||
| + | |||
Late | |||
| + | |||
Early | |||
|NL | |||
or | or ↓ | ||
|↑↑ | |||
|50% | |||
|NL | |||
|↓ | |||
|Markedly | |||
decreased | decreased | ||
Line 551: | Line 552: | ||
texture | texture | ||
|Lymphocytic | |||
infiltration | infiltration & follicles | ||
|CD4 | |||
T-cell | T-cell | ||
Line 567: | Line 564: | ||
mutation | mutation | ||
|- | |- | ||
|[[Postpartum thyroiditis]] | |||
| + | |||
|Small | |||
painless goiter | painless goiter | ||
| + | |||
Late | |||
| + | |||
Early | |||
|NL | |||
or | or ↓ | ||
|↑↑ | |||
|>80% | |||
|↑ | |||
|↓ | |||
|Hypoechoic | |||
diffusely | diffusely | ||
Line 593: | Line 590: | ||
or decreased | or decreased | ||
vascularity | |||
|Lymphocytic | |||
infiltration & follicles | |||
|Reg | |||
T-cell | T-cell | ||
Line 611: | Line 604: | ||
mutation | mutation | ||
|- | |- | ||
|[[De Quervain's thyroiditis|Subacute (de Quervain's)]] | |||
[[De Quervain's thyroiditis|granulomatous thyroiditis]] | [[De Quervain's thyroiditis|granulomatous thyroiditis]] | ||
| + | |||
|Small | |||
painful | painful | ||
mass | mass | ||
| + | |||
late | late | ||
| + | |||
early | early | ||
|nl | |||
or | or ↓ | ||
|↑↑ | |||
|neg | |||
|↑ | |||
|↓ | |||
|Diffusely | |||
enlarged & | enlarged & | ||
Line 636: | Line 629: | ||
decreased | decreased | ||
vascularity | |||
|Giant cells | |||
granulomas | |||
|Systemic | |||
viral | viral | ||
Line 647: | Line 640: | ||
infections | infections | ||
|- | |- | ||
|[[Factitious thyrotoxicosis|Factitious]] | |||
[[Factitious thyrotoxicosis|thyrotoxicosis]] | [[Factitious thyrotoxicosis|thyrotoxicosis]] | ||
| + | |||
|Nl | |||
|Neg | |||
| + | |||
Early | |||
|NL | |||
or | or ↓ | ||
|↑↑ | |||
|Neg | |||
|NL | |||
|↓ | |||
|NL | |||
|Normal | |||
histology | histology | ||
|Thyroixine | |||
intake | intake | ||
|- | |- | ||
|Acute suppurative | |||
thyroiditis | thyroiditis | ||
| + | |||
|Small | |||
painful | painful | ||
mass | mass | ||
| + | |||
Late | |||
| + | |||
Early | |||
|NL | |||
or | or ↓ | ||
|↑↑ | |||
|Neg | |||
|↑ | |||
|↓ | |||
|Variable | |||
heterogeneous | heterogeneous | ||
Line 698: | Line 691: | ||
space due to | space due to | ||
abscess | |||
|Polymorphonuclear | |||
leukocytes | |||
lymphocytes | lymphocytes | ||
exudates | exudates | ||
|Viral, Bacterial | |||
|- | |- | ||
! rowspan="3" |Destructive | ! rowspan="3" |Destructive | ||
hyperthyroidism | hyperthyroidism | ||
| rowspan="3" |4-6 | |||
|[[De Quervain's thyroiditis|Subacute (de Quervain's)]] | |||
[[De Quervain's thyroiditis|granulomatous thyroiditis]] | [[De Quervain's thyroiditis|granulomatous thyroiditis]] | ||
| + | |||
|Small | |||
painful | painful | ||
mass | mass | ||
| + | |||
Late | |||
| + | |||
Early | |||
|NL | |||
or | or ↓ | ||
|↑↑ | |||
|Neg | |||
|↑ | |||
|↓ | |||
|Diffusely | |||
enlarged | enlarged | ||
&normal or | & normal or | ||
decreased | decreased | ||
vascularity | |||
|Gaint cells | |||
granulomas | |||
|Systemic | |||
viral | viral | ||
Line 747: | Line 739: | ||
infections | infections | ||
|- | |- | ||
|[[Postpartum thyroiditis|Postpartum]] | |||
[[Postpartum thyroiditis|thyroiditis]] | [[Postpartum thyroiditis|thyroiditis]] | ||
| + | |||
|Small | |||
painless | painless | ||
goiter | goiter | ||
| + | |||
Late | |||
| + | |||
Early | |||
|NL | |||
or | or ↓ | ||
|↑↑ | |||
|>80% | |||
|↑ | |||
|↓ | |||
|Hypoechoic | |||
diffusely | diffusely | ||
Line 774: | Line 766: | ||
decreased | decreased | ||
vascularity | |||
|Lymphocytic | |||
infiltration & | |||
follicles | |||
|Reg | |||
T-cell | T-cell | ||
Line 792: | Line 780: | ||
mutation | mutation | ||
|- | |- | ||
|Acute suppurative | |||
thyroiditis | thyroiditis | ||
| + | |||
|Small | |||
painful | painful | ||
mass | mass | ||
| + | |||
Late | |||
| + | |||
Early | |||
|NL | |||
or | or ↓ | ||
|↑↑ | |||
|neg | |||
|↑ | |||
|↓ | |||
|Variable | |||
heterogeneous | heterogeneous | ||
Line 821: | Line 809: | ||
space due to | space due to | ||
abscess | |||
|Polymorphonuclear leukocytes | |||
lymphocytes | lymphocytes | ||
Line 828: | Line 816: | ||
exudates | exudates | ||
|Viral, | |||
Bacterial | |||
|- | |- | ||
! rowspan="4" |'''Transient''' | |||
'''hypothyroidism''' | '''hypothyroidism''' | ||
| rowspan="4" |2-4 | | rowspan="4" |2-4 | ||
Line 840: | Line 828: | ||
|Small | |Small | ||
painless | painless | ||
goiter | goiter | ||
| | | + | ||
Late | |||
| | | + | ||
Early | |||
| | |NL | ||
or | or ↑ | ||
| | |↓ | ||
|>80% | |>80% | ||
|↑ | |↑ | ||
|↓ | |↓ | ||
| | | Hypoechoic | ||
diffusely | diffusely | ||
Line 862: | Line 851: | ||
vasclarity | vasclarity | ||
| | |Lymphocytic | ||
infiltration & | |||
follicles | |||
|Reg | |Reg | ||
Line 883: | Line 868: | ||
| + | | + | ||
|Small | |Small | ||
painless | painless | ||
goiter | goiter | ||
| | | + | ||
Late | |||
| | | + | ||
Early | |||
| | |NL | ||
or | or ↑ | ||
| | |↓ | ||
| | | + | ||
|NL | |NL | ||
|↓ | |↓ | ||
| | |Markedly | ||
decreased | decreased | ||
Line 908: | Line 894: | ||
|Lymphocytic infiltration | |Lymphocytic infiltration | ||
& follicles | |||
|CD4 | |CD4 | ||
Line 924: | Line 909: | ||
|Small | |Small | ||
painful | painful | ||
mass | mass | ||
| | | + | ||
Late | |||
| | | + | ||
Early | |||
| | |NL | ||
or | or ↑ | ||
| | |↓ | ||
| | |Neg | ||
|↑ | |↑ | ||
|↓ | |↓ | ||
| | |Diffusely | ||
enlarged | enlarged | ||
Line 944: | Line 930: | ||
vasclarity | vasclarity | ||
|Giant cells | |Giant cells & | ||
granulomas | |||
| | |Systemic | ||
viral | viral | ||
Line 954: | Line 940: | ||
infections | infections | ||
|- | |- | ||
| | |Acute suppurative | ||
thyroiditis | |||
| + | | + | ||
|Small | |Small | ||
painful | painful | ||
mass | mass | ||
| | | + | ||
Late | |||
| | | + | ||
Early | |||
| | |NL | ||
or | or ↑ | ||
| | |↓ | ||
| | |Neg | ||
|↑ | |↑ | ||
|↓ | |↓ | ||
| | |Variable | ||
heterogeneous | heterogeneous | ||
Line 983: | Line 970: | ||
abcess | abcess | ||
| | |Polymorphonuclear leukocytes | ||
lymphocytes | lymphocytes | ||
exudates | exudates | ||
| | |Infections | ||
viral,bacterial | viral,bacterial | ||
|- | |- | ||
! rowspan="4" |'''Persistent''' | |||
'''hypothyroidism''' | '''hypothyroidism''' | ||
| rowspan="4" |6 | | rowspan="4" |6 | ||
Line 999: | Line 986: | ||
| + | | + | ||
|Small | |Small | ||
painful | painful | ||
mass | mass | ||
| | | + | ||
Late | |||
| | | + | ||
Early | |||
| | |↑ | ||
| | |↓ | ||
|75% | |75% | ||
|↑ | |↑ | ||
|↓ | |↓ | ||
| | |Homogeneously | ||
hypoechoic | hypoechoic | ||
Line 1,020: | Line 1,008: | ||
structures | structures | ||
| | |Lymphocytes, plasma cells, and eosinophils in a dense matrix of hyalinized connective tissue | ||
| | |Viral | ||
Bacterial | |||
|- | |- | ||
|[[Postpartum thyroiditis|Postpartum]] | |[[Postpartum thyroiditis|Postpartum]] | ||
Line 1,030: | Line 1,017: | ||
|Small | |Small | ||
painless | painless | ||
goiter | goiter | ||
| | | + | ||
Late | |||
| | | + | ||
Early | |||
| | |↑ | ||
| | |↓ | ||
|>80% | |>80% | ||
|↑ | |↑ | ||
|↓ | |↓ | ||
| | |Hypoechoic | ||
diffusely | diffusely | ||
Line 1,050: | Line 1,038: | ||
vasclarity | vasclarity | ||
| | |Variable | ||
heterogeneous | heterogeneous | ||
Line 1,072: | Line 1,060: | ||
|Painful | |Painful | ||
mass | mass | ||
| | | + | ||
Late | |||
| | | + | ||
Early | |||
| | |↑ | ||
| | |↓ | ||
|95% | |95% | ||
|↑ | |↑ | ||
|↓ | |↓ | ||
| | |Heterogeneous | ||
echotexture | echotexture | ||
Line 1,091: | Line 1,079: | ||
micronodules | micronodules | ||
| | |Lymphoid | ||
follicles | follicles | ||
germinal centers | |||
Hurthle cells | Hurthle cells | ||
Line 1,107: | Line 1,095: | ||
| + | | + | ||
|Small | |Small | ||
painful | painful | ||
mass | mass | ||
| | | + | ||
Late | |||
| | | + | ||
Early | |||
| | |↑ | ||
| | |↓ | ||
| | |Neg | ||
|↑ | |↑ | ||
|↓ | |↓ | ||
| | |Variable | ||
heterogeneous | heterogeneous | ||
Line 1,131: | Line 1,120: | ||
abcess | abcess | ||
| | |Polymorphonuclear leukocytes | ||
lymphocytes | lymphocytes | ||
exudates | exudates | ||
| | |Systemic | ||
viral | viral |
Latest revision as of 19:21, 25 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]Sunny Kumar MD [3]
Overview
Postpartum thyroiditis must be differentiated from other causes of thyroiditis, such as De Quervain's thyroiditis, Hashimoto's thyroiditis, Riedel's thyroiditis, and suppurative thyroiditis. Postpartum thyroiditis must also be differentiated from other diseases which cause hypothyroidism. As postpartum thyroiditis may cause transient thyrotoxic symptoms, the diseases causing thyrotoxicosis must also be considered in the differential diagnosis.
Differentiating Postpartum Thyroiditis from other Diseases
Differentiating postpartum thyroiditis from other causes of thyroiditis
- Postpartum thyroiditis must be differentiated from other causes of thyroiditis, such as De Quervain's thyroiditis, Hashimoto's thyroiditis, Riedel's thyroiditis, and suppurative thyroiditis.[1][2][3]
Conditions | Causes | Age of onset (years) | Pathological findings | Diagnostic approach |
---|---|---|---|---|
Hashimoto's thyroiditis |
|
|
| |
Painful subacute (De Quervain's) thyroiditis |
|
|
| |
Silent thyroiditis |
|
|
| |
Postpartum thyroiditis |
|
|
| |
Riedel's thyroiditis |
|
|
|
|
Suppurative thyroiditis |
|
|
|
Differentiating postpartum thyroiditis from other causes of hypothyroidism
- Postpartum thyroiditis must be differentiated from other causes of hypothyroidism on the basis of history and symptoms and laboratory findings:[4][5][1][6][7][8]
Disease | History and symptoms | Laboratory findings | Additional findings | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Pain | TSH | Free T4 | T3 | T3RU† | Thyroglobin | TRH | TPOAb^ | |||
Primary hypothyroidism | Autoimmune | - | - | ↑* | ↓ | Normal/↓ | Normal/↓ | Normal/↑ | Normal | Present (high titer) |
|
Riedel's thyroiditis | - | - | Normal/↑ | Normal/↓ | Normal/↓ | Normal/↓ | Normal | Normal | Usually present |
| |
Infectious thyroiditis | + | + | Normal | Normal | Normal | Normal | Normal | Normal | Absent |
| |
Transient hypothyroidism | Subacute (de Quervain's) thyroiditis | +/- | +/- | ↑/↓ | ↓/↑ | Normal | ↓ | ↑ | Normal | Low/absent |
|
Postpartum thyroiditis | +/- | +/- | ↑/↓ | ↓/↑ | Normal | ↓ | ↑ | Normal/↑ | Present (high titer) |
| |
Silent thyroiditis | - | - | ↑/↓ | ↓/↑ | Normal | ↓ | ↑ | Normal | Present (high titer) |
| |
Others | Drug-induced | - | - | ↑/↓ | ↓/↑ | Normal | ↓ | Normal/↑ | Normal | Absent** |
|
Radiation-induced | |||||||||||
Trauma induced | |||||||||||
Radioiodine induced | |||||||||||
Thyroidectomy | |||||||||||
Subclinical hypothyroidism | - | - | ↑ | Normal | Normal | Normal | Normal | Normal | Normal/↑ |
|
(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; Thyroid peroxidase antibodies. (*)TSH may be decreased transiently in the thyrotoxicosis. (**)TPOAb may be present in drug-induced hypothyroidism or hyperthyroidism such as Interferon-alpha, interleukin-2, and lithium.
Differentiating postpartum thyroiditis from other causes of thyrotoxicosis
- Postpartum thyroiditis can initially present with thyrotoxicosis which must be differentiated from other causes of thyrotoxicosis.[4][5][1][6][7][8][9][10][11]
Disease | History and symptoms | Laboratory findings | Additional findings | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Pain | TSH | Free T4 | T3 | T3RU† | Thyroglobin | TRH | TSH Receptor Antibody | TPOAb^ | |||
Thyroiditis | Postpartum thyroiditis | +/- | +/- | ↑/↓ | ↓/↑ | Normal | ↓ | ↑ | Normal/↑ | Absent | Present (high titer) |
|
Hashimoto's thyroiditis (Hashitoxicosis) | - | - | ↑* | ↓ | Normal/↓ | Normal/↓ | Normal/↑ | Normal | Absent | Present (high titer) |
| |
Subacute (de Quervain's) thyroiditis | +/- | +/- | ↑/↓ | ↓/↑ | Normal | ↓ | ↑ | Normal | Absent | Low/absent |
| |
Silent thyroiditis | - | - | ↑/↓ | ↓/↑ | Normal | ↓ | ↑ | Normal | Absent | Present (high titer) |
| |
Primary hyperthyroidism | Grave's disease | - | - | ↓ | ↑ | Normal/↑ | ↑ | ↑ | Normal | Present | Absent |
|
Toxic thyroid nodule | - | - | ↓ | ↑ | Normal/↑ | ↑(hot nodule) | Normal/↑ | Normal | Absent | Absent |
- | |
Secondary hyperthyroidism | Pituitary adenoma | - | - | ↑ | ↑ | Normal/↑ | ↑ | Normal/↑ | Normal | Absent | Absent |
|
Tertiary hyperthyroidism | Tertiary hyperthyroidism | - | - | ↑ | ↑ | ↑ | ↑ | Normal/↑ | ↑ | Absent | Absent |
|
Drug induced | Amiodarone type 1 | - | - | ↓ | ↑ | Normal/↑ | ↓ | Normal/↑ | Normal | Absent | Absent |
|
Amiodarone type 2 | - | - | ↓ | ↑ | Normal/↑ | Absent/↓ | Normal/↑ | Normal | Absent | Absent |
| |
Others | Factitious thyrotoxicosis | - | - | ↓ | ↑ | Normal/↑ | ↓ | ↓ | Normal | Absent | Absent |
|
Trophoblastic disease | - | - | ↓ | ↑ | Normal/↑ | ↑ | - | Normal | Absent | Absent |
- | |
Struma ovarii | - | - | ↓ | ↑ | Normal/↑ | ↓ | - | Normal | Absent | Absent |
- |
(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; Thyroid peroxidase antibodies.
Differentiating various diseases on the basis of type of thyroid dysfunction
Stages | Peek
presenting purpural month |
Disease | Symptoms and Signs | Labs | Mechanisum | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fatiuge | Neck
swelling |
Low
mood |
Irritability | TSH | FT4 | TPO ab | ESR | RAI
U |
Thyroid U/S | Microscopic
Picture | ||||
Persistent
hyperthyroidism |
4-6 | Grave's disease | + | Small
painful mass |
+ | +
Early |
↓ | ↑↑ | Neg | ↑ | ↑ | Diffusely
enlarged hypervascular heterogeneous echotexture |
hyperplastic
follicles due to eosinophilic cytoplasm scalloping |
TSHR
activating antibodies |
Transient
hyperthyroidism |
2-4 | Silent thyroiditis | + | Small
painless goiter |
+
Late |
+
Early |
NL
or ↓ |
↑↑ | 50% | NL | ↓ | Markedly
decreased vascularity variable heterogeneous texture |
Lymphocytic
infiltration & follicles |
CD4
T-cell activation mutation |
Postpartum thyroiditis | + | Small
painless goiter |
+
Late |
+
Early |
NL
or ↓ |
↑↑ | >80% | ↑ | ↓ | Hypoechoic
diffusely enlarged with normal or decreased vascularity |
Lymphocytic
infiltration & follicles |
Reg
T-cell gain in function mutation | ||
Subacute (de Quervain's) | + | Small
painful mass |
+
late |
+
early |
nl
or ↓ |
↑↑ | neg | ↑ | ↓ | Diffusely
enlarged & normal or decreased vascularity |
Giant cells
granulomas |
Systemic
viral infections | ||
Factitious | + | Nl | Neg | +
Early |
NL
or ↓ |
↑↑ | Neg | NL | ↓ | NL | Normal
histology |
Thyroixine
intake | ||
Acute suppurative
thyroiditis |
+ | Small
painful mass |
+
Late |
+
Early |
NL
or ↓ |
↑↑ | Neg | ↑ | ↓ | Variable
heterogeneous texture perithyroidal hypoechoic space due to abscess |
Polymorphonuclear
leukocytes lymphocytes exudates |
Viral, Bacterial | ||
Destructive
hyperthyroidism |
4-6 | Subacute (de Quervain's) | + | Small
painful mass |
+
Late |
+
Early |
NL
or ↓ |
↑↑ | Neg | ↑ | ↓ | Diffusely
enlarged & normal or decreased vascularity |
Gaint cells
granulomas |
Systemic
viral infections |
Postpartum | + | Small
painless goiter |
+
Late |
+
Early |
NL
or ↓ |
↑↑ | >80% | ↑ | ↓ | Hypoechoic
diffusely enlarged& normal or decreased vascularity |
Lymphocytic
infiltration & follicles |
Reg
T-cell gain in function mutation | ||
Acute suppurative
thyroiditis |
+ | Small
painful mass |
+
Late |
+
Early |
NL
or ↓ |
↑↑ | neg | ↑ | ↓ | Variable
heterogeneous texture perithyroidal hypoechoic space due to abscess |
Polymorphonuclear leukocytes
lymphocytes exudates |
Viral,
Bacterial | ||
Transient
hypothyroidism |
2-4 | Postpartum | + | Small
painless goiter |
+
Late |
+
Early |
NL
or ↑ |
↓ | >80% | ↑ | ↓ | Hypoechoic
diffusely enlarged & normal or decreased vasclarity |
Lymphocytic
infiltration & follicles |
Reg
T-cell gain in function mutation |
Silent | + | Small
painless goiter |
+
Late |
+
Early |
NL
or ↑ |
↓ | + | NL | ↓ | Markedly
decreased vascularity variable heterogeneous texture |
Lymphocytic infiltration
& follicles |
CD4
T-cell activation mutation | ||
Subacute (de Quervain's) | + | Small
painful mass |
+
Late |
+
Early |
NL
or ↑ |
↓ | Neg | ↑ | ↓ | Diffusely
enlarged normal or decreased vasclarity |
Giant cells &
granulomas |
Systemic
viral infections | ||
Acute suppurative
thyroiditis |
+ | Small
painful mass |
+
Late |
+
Early |
NL
or ↑ |
↓ | Neg | ↑ | ↓ | Variable
heterogeneous texture perithyroidal hypoechoic space due to abcess |
Polymorphonuclear leukocytes
lymphocytes exudates |
Infections
viral,bacterial | ||
Persistent
hypothyroidism |
6 | Riedel's | + | Small
painful mass |
+
Late |
+
Early |
↑ | ↓ | 75% | ↑ | ↓ | Homogeneously
hypoechoic fibrotic invasion of the adjacent structures |
Lymphocytes, plasma cells, and eosinophils in a dense matrix of hyalinized connective tissue | Viral
Bacterial |
Postpartum | + | Small
painless goiter |
+
Late |
+
Early |
↑ | ↓ | >80% | ↑ | ↓ | Hypoechoic
diffusely enlarged& normal or decreased vasclarity |
Variable
heterogeneous texture, hypoechogenic |
Reg
T-cell gain in function mutation | ||
Hashimoto's | + | Painful
mass |
+
Late |
+
Early |
↑ | ↓ | 95% | ↑ | ↓ | Heterogeneous
echotexture decreased vasclarity hypoechoic micronodules |
Lymphoid
follicles germinal centers Hurthle cells |
Reg T-cell
dysfunction | ||
Acute suppurative
thyroiditis |
+ | Small
painful mass |
+
Late |
+
Early |
↑ | ↓ | Neg | ↑ | ↓ | Variable
heterogeneous texture perithyroidal hypoechoic space due to abcess |
Polymorphonuclear leukocytes
lymphocytes exudates |
Systemic
viral infections |
References
- ↑ 1.0 1.1 1.2 "Thyroiditis — NEJM".
- ↑ Akuzawa N, Yokota T, Suzuki T, Kurabayashi M (2017). "Acute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report". Clin Case Rep. 5 (8): 1238–1242. doi:10.1002/ccr3.1048. PMC 5538065. PMID 28781832.
- ↑ Akuzawa N, Yokota T, Suzuki T, Kurabayashi M (2017). "Acute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report". Clin Case Rep. 5 (8): 1238–1242. doi:10.1002/ccr3.1048. PMC 5538065. PMID 28781832.
- ↑ 4.0 4.1 Bindra A, Braunstein GD (2006). "Thyroiditis". Am Fam Physician. 73 (10): 1769–76. PMID 16734054.
- ↑ 5.0 5.1 McDermott MT (2009). "In the clinic. Hypothyroidism". Ann. Intern. Med. 151 (11): ITC61. doi:10.7326/0003-4819-151-11-200912010-01006. PMID 19949140.
- ↑ 6.0 6.1 Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR (2007). "Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002)". Thyroid. 17 (12): 1211–23. doi:10.1089/thy.2006.0235. PMID 18177256.
- ↑ 7.0 7.1 Lania A, Persani L, Beck-Peccoz P (2008). "Central hypothyroidism". Pituitary. 11 (2): 181–6. doi:10.1007/s11102-008-0122-6. PMID 18415684.
- ↑ 8.0 8.1 De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J. "Clinical Strategies in the Testing of Thyroid Function". PMID 25905413.
- ↑ "Clinical Finding and Thyroid Function in Women with Struma Ovarii".
- ↑ Vaidya B, Pearce SH (2014). "Diagnosis and management of thyrotoxicosis". BMJ. 349: g5128. PMID 25146390.
- ↑ "Think thyrotoxicosis factitia - measure thyroglobulin | The BMJ".